Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

Share Price Information for Argentex Group. (AGFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.80
Bid: 36.00
Ask: 37.00
Change: 0.90 (2.51%)
Spread: 1.00 (2.778%)
Open: 35.90
High: 37.70
Low: 32.60
Prev. Close: 35.90
AGFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update and Board changes

20 Jan 2021 07:00

RNS Number : 2311M
Argentex Group PLC
20 January 2021
 

20 January 2021

Argentex Group PLC ("Argentex")

Trading update and Board changes

Argentex, the provider of bespoke foreign exchange advisory and execution services to financial institutions, corporates and high net worth individuals today provides a trading update and announces a number of Board changes.

Trading update

Argentex is pleased to report that trading has continued to improve following the announcement of its Interim Results on 20 November 2020. Although the full effect of the latest lockdown has yet to be felt, the recent Brexit trade agreement and the successful implementation of the vaccine programme for Covid-19 provides the Board of Argentex with confidence that this encouraging trend, driven by a return to historic client trading behaviour, will continue for the remainder of the financial year to 31 March 2021.

Board changes

The Board is also pleased to announce the appointment of Jo Stent as Chief Financial Officer with effect from 1 February 2021. She has been a senior finance professional for 25 years, most recently as Chief Financial Officer of the European Tour and Ryder Cup Europe. She is a former CFO of Vodafone Americas having previously held senior positions at Telus Communications and Deloitte. Jo is a chartered accountant having qualified at EY. Jo will replace Sam Williams, who is leaving Argentex to pursue other opportunities, after a handover period of three months.

Carl Jani, Joint CEO, is taking a leave of absence from the business for health reasons with immediate effect. In this interim period, Harry Adams, Joint CEO, will assume the role of sole CEO.

 

Harry Adams, CEO said: "We are delighted to have attracted someone of Jo's calibre to Argentex. Her financial expertise and experience in global businesses will be a huge benefit to us as we continue to realise our growth ambitions. This is an exciting time for us as trading volumes return to pre-pandemic levels."

Lord Digby Jones, Chairman, commented: "I am pleased to welcome Jo to the Board of Argentex where her skills will be a major asset for us as we continue to grow. I'd also like to thank Sam for his dedication and hard work. He joined us in 2015 and was a key member of the team for our successful IPO in 2019. We wish him every success in the future.

"We all wish Carl well and hope he makes a full and speedy recovery."

For further information please contact:

 

FTI Consulting (Financial PR)

Ed Berry / Shiv Talwar / Ambrose Fullalove

Telephone: 07703 330 199

argentex@fticonsulting.com

 

 

Numis Securities Limited (Nominated Adviser and Broker)

Stephen Westgate, Charlie Farquhar, Laura White, Hugo RubinsteinTelephone: +44 (0) 20 7260 1000

 

Additional information:

Joanne Thomson Stent (formerly Fletcher, aged 46) is, or has been, a director or partner of the following companies or partnerships during the previous five years:

 

Current directorships:

Previous directorships (last 5 years):

The National Coaching Foundation

PGA European Tour Productions Limited

 

Fundación Andalusia Valderrama Masters

 

Coachwise Limited

 

Save as set out above there are no other disclosures in respect of the appointment of Jo Stent that fall to be made under Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLMPTMTJBBLB
Date   Source Headline
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company
11th Aug 20211:08 pmRNSHolding(s) in Company
11th Aug 20219:41 amRNSDirector/PDMR Shareholding
4th Aug 20216:08 pmRNSResult of AGM
29th Jul 20217:00 amRNSChange to AGM Arrangements
13th Jul 202112:04 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
5th Jul 20212:22 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSFull year results for period ending 31 March 2021
22nd Jun 20217:00 amRNSNotice of Results
11th Jun 20217:00 amRNSDirectorate Change
10th May 20217:00 amRNSManagement team update
12th Apr 20218:00 amRNSExtension of audit partner's tenure & audit tender
6th Apr 20217:00 amRNSTrading Update
26th Feb 20212:58 pmRNSDirector/PDMR Shareholding
17th Feb 20213:12 pmRNSHolding(s) in Company
9th Feb 20212:34 pmRNSHolding(s) in Company
20th Jan 20217:00 amRNSTrading update and Board changes
20th Nov 20207:00 amRNSInterim Results
19th Nov 20204:53 pmRNSHolding(s) in Company
4th Nov 20207:00 amRNSNotice of interim results
12th Oct 20207:00 amRNSDirector Declaration
12th Oct 20207:00 amRNSTrading Statement
6th Oct 20204:40 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20204:40 pmRNSSecond Price Monitoring Extn
30th Sep 20204:35 pmRNSPrice Monitoring Extension
21st Sep 20205:50 pmRNSChange of Registered Office
11th Sep 20202:18 pmRNSAGM Statement
7th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Aug 20207:17 amRNSAnnual Report and Notice of Annual General Meeting
3rd Aug 20207:00 amRNSFull year results for period ending 31 March 2020
29th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Full Year Results
8th Jul 20205:24 pmRNSHolding(s) in Company
29th Jun 20209:11 amRNSHolding(s) in Company
27th May 20207:00 amRNSArgentex Group announces new headquarters
26th May 20204:40 pmRNSSecond Price Monitoring Extn
26th May 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20205:40 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading Update
27th Mar 20204:41 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
25th Mar 20204:00 pmRNSDirector/PDMR Shareholding
18th Mar 202011:46 amRNSDirector/PDMR Shareholding
17th Mar 20204:43 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.